Docket HopperPart I · Bills · 119th H.R. 4525
H.R. 4525 · 119th CongressHealth

Right to FDA-Approved Medicines Act has not moved since its introduction on Jul 17, 2025, with cosponsors, all Democrats

Sponsored by Ross, Deborah K. D-NC · 29 cosponsors: 29 Democrats, 0 Republicans
IntroducedJul 17, 2025
Reported—
Passed one chamber—
Passed both—
Law—
What it changes · CRS summary

Written by the Congressional Research Service [2]. 152 words.

Right to FDA-Approved Medicines Act This bill sets out statutory protections for an individual's right to access and a health care provider's right to provide medicines (i.e., drugs and biological products) approved by the Food and Drug Administration (FDA). Generally, the bill prohibits measures that single out and impede access to FDA-approved medicines and related information. However, a party may defend against a claim that a measure violates the bill's prohibitions by demonstrating, through clear and convincing evidence, that the measure significantly advances access to FDA-approved medicines and such access cannot be advanced through less restrictive means. The bill also specifies that the prohibition preempts inconsistent state and local laws and applies in spite of other federal laws, including the Religious Freedom Restoration Act of 1993. The Department of Justice, individuals, or health care providers may bring a lawsuit to enforce this bill, and states are not immune from suits for violations.

Context
Committees
House Energy and Commerce Committee
Policy area
Health: 122 of 9,357 bills became law, 113th–118th (1.3%)
Sponsor
1 of 73 bills enacted since 2013
Text versions
1: introduced in house · 1,451 words
Latest action
Jul 17, 2025: Referred to the House Committee on Energy and Commerce.
Records
Congress.gov · Bill text
Exhibit 1Passage odds band at each stage, rated when the bill reached it [4]
Related bills · 0

The bill status record lists no related bills.

Exhibit 2Articles naming the bill per day, last 90 days, US sources [3]